ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      87.175
      0.30%
      Bitcoin
      57,494.52
      -4.43%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Gossamer Bio Inc (GOSS)

      7. Gossamer Bio Inc (GOSS) News

      GOSS

      Gossamer Bio (GOSS)

      Gossamer Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GOSS
      DateTimeSourceHeadlineSymbolCompany
      06/18/20204:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GOSSGossamer Bio Inc
      06/09/20204:34PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GOSSGossamer Bio Inc
      06/01/20207:35AMBusiness WireGossamer Bio Announces Participation in Upcoming Investor ConferencesNASDAQ:GOSSGossamer Bio Inc
      05/29/20208:07AMBusiness WireGossamer Bio Announces Early Encouraging Safety & Biomarker Data from Phase 1/2 Study of GB1275 at American Society of Clinic...NASDAQ:GOSSGossamer Bio Inc
      05/27/20204:30PMPR Newswire (US)Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation ...NASDAQ:GOSSGossamer Bio Inc
      05/21/20204:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GOSSGossamer Bio Inc
      05/19/20205:12PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GOSSGossamer Bio Inc
      05/19/20205:09PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GOSSGossamer Bio Inc
      05/19/20206:07AMEdgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:GOSSGossamer Bio Inc
      05/19/20201:24AMBusiness WireGossamer Bio Announces Pricing of Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027NASDAQ:GOSSGossamer Bio Inc
      05/18/20205:03PMEdgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:GOSSGossamer Bio Inc
      05/18/20204:27PMEdgar (US Regulatory)Initial Statement of Trust Indenture (305b2)NASDAQ:GOSSGossamer Bio Inc
      05/18/20204:17PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GOSSGossamer Bio Inc
      05/18/20204:12PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GOSSGossamer Bio Inc
      05/18/20204:01PMBusiness WireGossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes Due 2027NASDAQ:GOSSGossamer Bio Inc
      05/12/20204:33PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GOSSGossamer Bio Inc
      05/12/20204:30PMGlobeNewswire Inc.Aerpio Announces Amended Licensing Deal with Gossamer Bio on its Inflammatory Bowel Disease (IBD) Product Candidate GB004 (fo...NASDAQ:GOSSGossamer Bio Inc
      05/12/20204:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GOSSGossamer Bio Inc
      05/12/20204:01PMBusiness WireGossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:GOSSGossamer Bio Inc
      05/08/20207:37AMBusiness WireGossamer Bio to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 12, 2020NASDAQ:GOSSGossamer Bio Inc
      04/29/20207:02PMBusiness WireShareholder Alert: Robbins LLP Reminds Investors It Is Investigating Gossamer Bio, Inc. (GOSS) on Behalf of ShareholdersNASDAQ:GOSSGossamer Bio Inc
      04/27/20204:21PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GOSSGossamer Bio Inc
      04/27/20204:17PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GOSSGossamer Bio Inc
      04/10/20204:33PMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:GOSSGossamer Bio Inc
      04/08/20202:46PMBusiness WireShareholder Alert: Robbins LLP Announces It Is Investigating Gossamer Bio, Inc. (GOSS) on Behalf of ShareholdersNASDAQ:GOSSGossamer Bio Inc
      04/07/20209:10AMPR Newswire (US)Gossamer (GOSS) Class Action Alert: Johnson Fistel Encourages Investors to Contact FirmNASDAQ:GOSSGossamer Bio Inc
      03/24/20209:03AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:GOSSGossamer Bio Inc
      03/24/20208:46AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GOSSGossamer Bio Inc
      03/24/20207:00AMBusiness WireGossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
      02/19/20204:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GOSSGossamer Bio Inc
       Showing the most relevant articles for your search:NASDAQ:GOSS